Verify any claim · lenz.io
Claim analyzed
Health“A 2025 Robert Koch Institute report found that, in Germany, the proportion of adults diagnosed with a mental disorder in outpatient care increased from 35.0% in 2012 to 40.9% in 2022.”
Submitted by Merry Deer db87
The conclusion
Open in workbench →The increase itself is supported, but the claim overstates what the evidence shows. Available sources back a rise from 35.0% in 2012 to more than 40% in recent years, yet they do not substantiate the exact figure of 40.9% for 2022 or clearly tie it to a distinct 2025 Robert Koch Institute report. The wording also blurs that this is outpatient administrative diagnosis data, not overall population prevalence.
Caveats
- The exact 40.9% value for 2022 is not documented in the provided high-quality sources.
- The framing suggests a standalone 2025 RKI report, but the evidence points more to an updated indicator/time series than a clearly identified report with that figure.
- These numbers reflect diagnosed cases in outpatient administrative data among the relevant insured population, not the true prevalence of mental disorders among all adults in Germany.
This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
The 2025 DGPPN basic data report cites RKI administrative prevalence data: "In 2023, 40.4% of statutorily insured adults received a diagnosis of a mental disorder. 16.7% were diagnosed with depression, 7.9% with an anxiety disorder." It adds that this is based on: "Robert Koch-Institut (2024) Psychische Störungen: Administrative Prävalenz (ab 18 Jahre)." The report explains that administrative prevalence does not equal the true disease frequency because diagnoses may be over- or under-recorded and some affected people do not seek treatment.
The 2024 Versorgungsatlas report on incidence trends in 37 mental disorders among adults states that in 2022, about 7.5 of 60.9 million statutorily insured adults (18+) were documented for the first time after two years without diagnosis as having at least one mental or behavioral disorder (ICD‑10 F10–F99). It reports that from 2015 to 2022, the overall incidence rose by 27% (from 44.0 per 10,000 in 2015 to 55.9 per 10,000 in 2022), focusing on incidence (newly diagnosed cases) rather than the overall proportion of adults with any diagnosis in a given year.
This article describes results from the "RKI Panel 2024" and notes: "Telephone surveys show a decline in the mental health of adults in Germany between 2020 and 2023." It then reports that in 2024, an estimated 22% of adults had depressive symptoms and 14% had anxiety symptoms. The authors explain that these survey-based estimates complement administrative indicators from health insurance data used in RKI's official health reporting, such as the administrative prevalence of mental disorders.
Slides from an October 2025 presentation on outpatient diagnoses of mental disorders show a chart labeled "Ambulante Diagnosen psychischer Störungen" with baseline values for 2012. In the figure, under "Ergebnisse 2012–2023" the values listed for 2012 include "35,0" for "Psychische Störungen insgesamt (F00–F99)", "14,4" for depression and "5,8" for anxiety disorders, matching the RKI administrative prevalence series referenced with the URLs to the GBE indicators.
This Versorgungsatlas study (focusing on children and adolescents) uses nationwide statutory health insurance billing data. It notes that the incidence of diagnosed mental and behavioral disorders increased over time, with a continuous rise of certain diagnoses. Although it addresses incidence (new diagnoses) in youth rather than adult outpatient prevalence, it illustrates the broader trend of increasing diagnostic rates for mental disorders in routine care data.
A 2025 article in "Deutsches Ärzteblatt" reports on the RKI's indicator "Psychische Störungen: administrative Prävalenz (ab 18 Jahre)". It notes that, based on statutory health insurance data, the RKI shows a continuous increase in the proportion of adults with at least one outpatient diagnosis of a mental disorder since 2012, with the share now exceeding 40 percent in the latest year of observation.
RKI’s GBE-Bund indicator pages on administrative prevalence for mental disorders are live-updated series that typically present annual data up to the most recent year available (e.g., 2023 or 2024). While the data table includes all years (2012–2024), the accompanying narrative text on the indicator pages is generally updated in the year following the last data point (e.g., a text updated in 2025 summarizing trends up to 2024), rather than being labeled as a stand‑alone "2025 report" for 2012–2022 only.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
For developers
This same pipeline is available via API.
Verify your AI's output programmatically.
/extract pulls claims from text ·
/verify returns sourced verdicts ·
/ask answers follow-up questions.
Continue your research
Verify a related claim next.
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Official data presented by the Landeszentrum Gesundheit Nordrhein-Westfalen confirms that the baseline administrative prevalence of outpatient mental disorder diagnoses in Germany was 35.0% in 2012 (Source 4). Furthermore, a 2025 report in Deutsches Ärzteblatt on the Robert Koch Institute's official administrative prevalence indicators verifies that this proportion has risen continuously since 2012, officially exceeding 40 percent in the latest observation period (Source 6).
The Proponent conflates two separate data points from different sources to reconstruct a figure the claim presents as a single, unified finding: Source 4 confirms the 2012 baseline of 35.0%, and Source 6 confirms the series exceeded 40%, but neither source — nor any other in the research brief — establishes the specific figure of 40.9% for the year 2022 as attributed to a discrete '2025 RKI report.' Moreover, the Proponent ignores that Source 1 (DGPPN), the highest-authority source in the brief, cites RKI data showing 40.4% in 2023, not 40.9% in 2022, which directly contradicts the claim's precise figures and further undermines the assertion that a standalone 2025 RKI report documented this exact statistic.
Argument against
The claim specifically attributes a '2025 Robert Koch Institute report' showing 40.9% prevalence in 2022, but no source in the research brief confirms this precise figure or document — Source 1 (DGPPN) cites RKI data showing 40.4% in 2023, not 40.9% in 2022, and Source 6 (Ärzteblatt) only vaguely references the RKI series exceeding 40% without specifying 40.9% for 2022. Furthermore, Source 7 (LLM Background Knowledge) clarifies that RKI's administrative prevalence data is a live-updated series rather than a standalone '2025 report,' undermining the claim's framing of a discrete 2025 RKI publication reporting specifically on 2012–2022 figures.
The Opponent's argument relies on a literalist fallacy regarding the term "report," ignoring that the Robert Koch Institute's official administrative prevalence data is published and updated as a formal health reporting series (Source 3, Source 7). Furthermore, the Opponent fails to recognize that the 35.0% baseline in 2012 and the continuous rise exceeding 40% are explicitly verified by RKI-linked data and national medical reporting (Source 4, Source 6).
Expert review
3 specialized AI experts evaluated the evidence and arguments.
Expert 1 — The Logic Examiner
While Source 4 and Source 6 confirm the 2012 baseline of 35.0% and a general increase exceeding 40% in RKI's administrative prevalence data, the specific figure of 40.9% for the year 2022 is not documented in the provided evidence. Furthermore, Source 1 cites a 2023 RKI figure of 40.4%, which logically conflicts with the claim's assertion of a higher 40.9% rate in the preceding year of 2022.
Expert 2 — The Context Analyst
The claim is framed as a discrete “2025 Robert Koch Institute report” with a precise 2022 value (40.9%), but the evidence provided only supports (a) a 2012 baseline of 35.0% from an RKI-linked slide deck (Source 4) and (b) a general statement that the share exceeded 40% in recent years (Source 6), while the closest concrete RKI-cited figure in the pool is 40.4% for 2023 (Source 1) and the RKI series is described as a live-updated indicator rather than a standalone 2025 report (Source 7). With the key 40.9%-in-2022 figure and the “2025 RKI report” attribution not actually substantiated here—and partially in tension with the 2023 figure cited elsewhere—the overall impression is misleading rather than reliably true.
Expert 3 — The Source Auditor
The highest-authority sources (Source 1, DGPPN citing RKI data; Source 4, LZG NRW presentation; Source 6, Ärzteblatt) confirm the 2012 baseline of 35.0% and a continuous rise exceeding 40%, but none independently verify the specific figure of 40.9% for 2022 attributed to a discrete '2025 RKI report' — Source 1 cites 40.4% for 2023, not 40.9% for 2022, and Source 6 only vaguely references the series exceeding 40%. The claim's core directional trend is supported by credible, high-authority sources, but the precise figure (40.9% in 2022) and the framing of a standalone '2025 RKI report' are not confirmed by any trustworthy source, making the claim misleading in its specifics even if broadly directionally accurate.